By Tag

“Keep investing in expanding manufacturing capacity is our commitment to customers”

by admin February 10, 2022 No comments Expert Talk

Responding to the increased demand for products that are used in emerging modalities such as gene therapy, and are currently in high demand for the manufacture of COVID-19 vaccines and therapies, Cytiva is investing $1.5 billion over two years to meet growing demand for biotechnology solutions. Investment follows five strategic acquisitions made by the companies […]

Read more

Featured Companies

Newsletter

Stay connected with us.
Supportscreen tag